Genelux Corporation (GNLX)
(Delayed Data from NSDQ)
$3.15 USD
-0.19 (-5.69%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $3.14 -0.01 (-0.32%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Genelux Corporation's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
GNLX 3.15 -0.19(-5.69%)
Will GNLX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GNLX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GNLX
Genelux Corporation (GNLX) Upgraded to Buy: Here's What You Should Know
Is EUROFINS SCIENT (ERFSF) Outperforming Other Medical Stocks This Year?
GNLX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Down -29.7% in 4 Weeks, Here's Why Genelux Corporation (GNLX) Looks Ripe for a Turnaround
Other News for GNLX
Genelux GAAP EPS of -$0.20 beats by $0.02
Genelux reports Q2 EPS (20c), consensus (22c)
Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business ...
Genelux (GNLX) Receives Buy Rating from Lucid Capital | GNLX Stock News
Genelux initiated with bullish view at Lucid Capital, here's why